Clinical Trials Browser

Available × INDUSTRY × brexucabtagene autoleucel × Clear all

NCT05776134 2025-01-10

Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

LymphoidOther hematologic neoplasm

Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma